Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 20, 2022Blood Cancer JournalOpen Access

Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation

View Full Paper
Ask AI
Bookmark
Share

Authors

SAShady Adnan AwadUniversity of HelsinkiOBOscar BrückUniversity of HelsinkiNSNaranie ShanmuganathanRoyal Adelaide Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Awad et al. (2022) studied this question.

synapsesocial.com/papers/6a6ed00775498292b70860achttps://doi.org/10.1038/s41408-022-00667-9
View Full Paper
Ask AI
Bookmark
Share